Maxim Announces 2005 Second Quarter Financial Results

Maxim Pharmaceuticals announced results for the quarter ended March 31, 2005, the second quarter of its fiscal year. The net loss applicable to common stock for the quarter totaled $6.6 million or $0.23 per share, compared to a net loss applicable to common stock of $8.9 million or $0.32 per share, for the prior-year quarter. The net loss applicable to common stock for the six months ended March 31, 2005 totaled $16.2 million or $0.57 per share, compared to a net loss applicable to common stock of $18.8 million or $0.67 per share for the same period in the prior year.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20050502005429&newsLang=en)